InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,303.27
(
0.12%
)
US TECH 100
18,066.00
(
-0.07%
)
Dow Jones
40,003.59
(
0.34%
)
Brent Oil
83.76
(
0.00%
)
Bitcoin
66,929.93
(
-0.22%
)
Post# of 251852
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

AlpineBV_Miller

Send PM Follow Ignore
Followers 56
Posts 1150
Boards Moderated 0
Alias Born 11/12/2005

AlpineBV_Miller

Re: biot post# 72348

Thursday, 01/29/2009 1:21:59 AM

Thursday, January 29, 2009 1:21:59 AM

Post# of 251852
Oh geeez, relax. All I'm saying is that it would unlikely be the first choice for most of the people I've spoken with. The number of successful MAbs created with MEDX tech pales compared to the mainstream tech. Also, MEDX as not the only "independent" MAb producer left after the acquisition spree because they weren't interested in selling or asking for too much money in comparison to the other technologies.

Unless otherwise indicated, this is the personal viewpoint of David Miller and not necessarily that of Biotech Stock Research, LLC

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up